清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

[Disease burden and economic burden of breast cancer in females in China: a synthesis analysis].

中国 疾病 乳腺癌 疾病负担 疾病负担 医学 癌症 政治学 内科学 法学
作者
Xiaoyan Zhou,Xishan Wang,Y J Li,Yongjian Wu,Lei Wang,Huili Wang,Jufang Shi
出处
期刊:PubMed [National Institutes of Health]
卷期号:45 (9): 1185-1196 被引量:2
标识
DOI:10.3760/cma.j.cn112338-20240129-00048
摘要

Objective: To understand the current and integrated disease burden and economic burden caused by breast cancer in females in China. Methods: Based on six updated data sources, including the series of Chinese Cancer Registry Annual Report, China Death Cause Surveillance Datasets, China Health Statistical Yearbook, GLOBOCAN, Cancer Incidence in Five Continents, Global Burden of Disease Study (GBD), the information about incidence, mortality and disability adjusted life years (DALY) of breast cancer were extracted for the analysis on the current incidence and time trend of breast cancer and predicted disease burden of breast cancer in females in China. Software Joinpoint was used for time trend analysis. The data of economic burden were systematically updated and analyzed by literature review. Results: 1) GLOBOCAN 2022 estimated that the age-standardized incidence rate (ASIR) age-standardized mortality rate (ASMR) and one- year prevalence rate of breast cancer in females were 33.0/100 000, 6.1/100 000 and 40.1/100 000, respectively, in China in 2022. According to Chinese Cancer Registry Annual Report, the ASIR and ASMR were 28.4/100 000 and 5.8/100 000, respectively, in 2018. The China Death Cause Surveillance Datasets showed that the ASMR was 4.5/100 000 in 2021, and the urban to rural area mortality ratio was 1.2∶1. GBD reported that the DALYs of breast cancer were 2.921 million in China in 2021, accounting for 14.4% of the global total. 2) Chinese Cancer Registry Annual Report data showed that the ASIR and ASMR of breast cancer decreased by 2.1% and 11.4%, respectively, in China from 2009 to 2018, while increased by 43.9% and 8.2% in rural area, respectively. The Joinpoint analysis showed that the average annual percentage change (AAPC) of ASIR and ASMR in China were -0.2% (P>0.05) and -1.6% (P<0.05). The AAPC of ASIR and ASMR in rural area were 3.9% (P<0.05) and 0.6% (P>0.05), and -0.3% (P>0.05) and -1.2% (P<0.05) in urban area, respectively. China Health Statistical Yearbook data showed that the urban ASMR decreased by 12.3% from 2014 to 2021 with AAPC of -2.6% (P<0.05). 3) The GLOBOCAN 2022 predicted that, the breast cancer case count and death count in China would be 387 776 and 111 133 by 2050, an increase of 8.6% and 48.2%, respectively, compared with 2022, the increases would be more obvious in people over 65 years old, an increase of 80.8% and 124.9%, respectively. 4) Thirteen individual- based studies reported that the median medical expenditure per patient (M=21 000 to 39 000 Yuan) and length of hospital stay (M=11.0 to 30.5 days) for breast cancer treatment decreased from 2010 to 2019, while the average medical expenditure per visit (M=9 000 to 23 000 Yuan) showed an upward trend. There was only one national-level analysis, which showed that the treatment cost of breast cancer was 25.24 billion Yuan in China in 2018, accounting for 6.4% of the total cancer treatment cost. Conclusions: According to the above updated multi-source data, the incidence and mortality of female breast cancer in China were stable in the past ten years, but the increasing trend in rural area should be noted. The direct medical expenditure of breast cancer treatment per case might decrease, but the population-level economic burden would remain heavy due to population aging.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
淡然的冬瓜完成签到,获得积分10
4秒前
活力尔柳完成签到 ,获得积分10
6秒前
SunJay完成签到,获得积分10
11秒前
pingchangxinyi完成签到 ,获得积分10
12秒前
DH完成签到 ,获得积分10
18秒前
naczx完成签到,获得积分0
20秒前
ay完成签到,获得积分20
23秒前
飞快的蛋的应助被ay采纳,获得30
31秒前
34秒前
朴素的荧荧完成签到,获得积分10
38秒前
愉快的书桃完成签到,获得积分10
1分钟前
加油完成签到 ,获得积分10
1分钟前
pigff完成签到,获得积分10
1分钟前
系统昵称完成签到,获得积分10
1分钟前
白白完成签到,获得积分10
1分钟前
黑大侠完成签到 ,获得积分0
1分钟前
如意大神完成签到,获得积分10
1分钟前
武安发布了新的文献求助10
1分钟前
波波波波波6764完成签到 ,获得积分10
2分钟前
欢呼的听枫完成签到,获得积分10
2分钟前
狞风妖完成签到 ,获得积分10
2分钟前
syvshc的应助被科研通管家采纳,获得10
2分钟前
俭朴竺完成签到,获得积分10
2分钟前
超男完成签到 ,获得积分10
2分钟前
丰富凌晴完成签到,获得积分10
2分钟前
Ahui完成签到 ,获得积分10
2分钟前
优雅的梦芝完成签到,获得积分10
3分钟前
温柔的谷冬完成签到,获得积分10
3分钟前
3分钟前
ww发布了新的文献求助10
3分钟前
小伟跑位完成签到,获得积分10
4分钟前
满意的平凡完成签到,获得积分10
4分钟前
奥丁不言语完成签到 ,获得积分10
4分钟前
哈哈哈哈哈完成签到,获得积分10
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
4分钟前
勤奋笙的应助被科研通管家采纳,获得10
4分钟前
幽默绝悟完成签到,获得积分10
4分钟前
北鲲居士完成签到,获得积分10
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185483
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834498
捐赠科研通 7783071
什么是DOI,文献DOI怎么找? 3434576
关于科研通互助平台的介绍 2558920
邀请新用户注册赠送积分活动 2481346